Elevance Health (ELV) reported Q1 adjusted earnings Tuesday of $11.97 per diluted share, up from $10.83 a year earlier.

A single analyst polled by FactSet expected operating EPS of $10.95.

Operating revenue for the quarter ended March 31 was $48.77 billion compared with $42.27 billion a year earlier.

Analysts surveyed by FactSet expected $46.30 billion.

The company reaffirmed its 2025 adjusted diluted EPS guidance range of $34.15 to $34.85.